Finance

Lists
WAT:NYSE
Waters Corp
USD 442,83
+1,97%
(+8,56) 1D
USD 449,13
+1,42% (+6,30)
After hours
Closed: 20 Okt., 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WAT...
Open
USD 434,36
High
USD 448,03
Low
USD 427,97
Mkt. cap
43,51 mjd
Avg. vol.
802,06 k
Volume
776,76 k
P/E ratio
110,74
52-wk high
USD 454,54
52-wk low
USD 282,77
EPS
USD 4,00
Beta
1,15
Shares outstanding
98,25 m
No. of employees
8 k
Open
USD 434,36
High
USD 448,03
Low
USD 427,97
Mkt. cap
43,51 mjd
Avg. vol.
802,06 k
Volume
776,76 k
P/E ratio
110,74
52-wk high
USD 454,54
52-wk low
USD 282,77
EPS
USD 4,00
Beta
1,15
Shares outstanding
98,25 m
No. of employees
8 k
News stories
From web sources and news partners
Profile
Waters Corporation is an American company headquartered in Milford, Massachusetts that provides analytical instruments and software used for chromatography, mass spectrometry, laboratory informatics, and rheometry by the life sciences, materials, and food industries. The company has primary manufacturing facilities in 9 U.S. locations as well as 11 international locations including Wexford, Wilmslow, Birmingham, Hüllhorst, Singapore, Bangalore, Beijing, and Shanghai. Major brands include ACQUITY UPC² / UPLC Systems and columns, Xevo mass spectrometry systems, Synapt MS / HDMS systems, Zodiac HPLC columns, XTerra HPLC columns, XBridge columns, Alliance HPLC systems, Empower chromatography software, MassLynx mass spectrometry software, Oasis sample preparation products, and NuGenesis lab management system. Its primary competitors are Agilent Technologies, Thermo Fisher Scientific, Revvity, and Danaher. Wikipedia
About Waters Corp
CEOUdit Batra
Employees7,9 k
Founded1958
HeadquartersMilford, Massachusetts, Verenigde State van Amerika
SectorHealth care
Websitewaters.com
Analyst ratings
Based on 17 analysts giving stock ratings to WAT in the past 3 months
Buy
Buy
12
Hold
5
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for WAT in the last 3 months.
Highest
Current USD 442,83
USD 515,00 (+16,30%)
Average
USD 463,13 (+4,58%)
Lowest
USD 400,00 (-9,67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eve Burstein
Bernstein
Buy
Reiterated
USD 450,00
+1,6%
10/19/2026
Casey Woodring
J.P. Morgan
Hold
Maintained
USD 435,00
-1,8%
10/16/2026
Daniel Brennan
TD Cowen
Buy
Maintained
USD 515,00
+16,3%
10/13/2026
‏Avantika Dhabaria‏
Bank of America Securities
Hold
Maintained
USD 465,00
+5%
10/09/2026
Michael Ryskin
Bank of America Securities
Hold
Maintained
USD 465,00
+5%
10/09/2026
Luke Sergott
Barclays
Buy
Maintained
USD 500,00
+12,9%
10/07/2026
Unknown Analyst
Jefferies
Buy
Maintained
USD 455,00
+2,7%
10/01/2026
Subbu Nambi
Guggenheim
Buy
Maintained
USD 490,00
+10,7%
10/01/2026
Evie Koslosky
Goldman Sachs
Buy
Reiterated
USD 515,00
+16,3%
09/20/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Maintained
USD 430,00
-2,9%
09/14/2026
Lu Li
UBS
Buy
Upgraded
USD 490,00
+10,7%
09/09/2026
Doug Schenkel
UBS
Buy
Upgraded
USD 490,00
+10,7%
09/09/2026
David Westenberg
Piper Sandler
Buy
Upgraded
USD 480,00
+8,4%
08/27/2026
Dan Leonard
RBC Capital
Buy
Maintained
USD 475,00
+7,3%
08/24/2026
Joanne Wuensch
Citi
Buy
Reiterated
USD 470,00
+6,1%
08/10/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
USD 420,00
-5,2%
08/05/2026
Justin Bowers
Deutsche Bank
Hold
Reiterated
USD 400,00
-9,7%
08/05/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
USD 440,00
-0,6%
08/04/2026
Daniel Arias
Stifel Nicolaus
Hold
Reiterated
USD 420,00
-5,2%
08/05/2026
Evan Stampler
Wells Fargo
Hold
Reiterated
USD 400,00
-9,7%
08/05/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
USD 400,00
-9,7%
08/05/2026
Matt Larew
William Blair
Buy
Maintained
-
-
08/04/2026
Sidharth Sahoo
HSBC
Buy
Maintained
USD 435,00
-1,8%
06/03/2026
Michael Polark
Wolfe Research
Buy
Maintained
USD 425,00
-4%
06/01/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
USD 370,00
-16,4%
05/14/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
USD 387,00
-12,6%
05/06/2026
Patrick B Donnelly
Citi
Buy
Reiterated
USD 425,00
-4%
04/07/2026
Tycho Peterson
Jefferies
Buy
Reiterated
USD 470,00
+6,1%
02/10/2026
Next call oor 14 dae
Di. 3 Nov., 15:00
Fiscal period
Q3 2026
- / USD 4,00
Revenue / Est. (USD)
- / 1,75 mjd
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Apr. 2026
Jul. 2026
Revenue
799,89 m
932,36 m
1,27 mjd
1,64 mjd
Cost of goods sold
327,81 m
362,86 m
679,00 m
757,00 m
Cost of revenue
327,81 m
362,86 m
679,00 m
757,00 m
Research and development expenses
53,64 m
46,90 m
95,00 m
121,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187,23 m
195,78 m
305,00 m
368,00 m
Operating expense
252,97 m
254,76 m
552,00 m
733,00 m
Total operating expenses
580,77 m
617,62 m
1,23 mjd
1,49 mjd
Operating income
219,11 m
314,74 m
36,00 m
155,00 m
Other non operating income
-69,00 k
2,06 m
1,00 m
-
EBT including unusual items
170,12 m
264,18 m
-88,00 m
-141,00 m
EBT excluding unusual items
197,12 m
308,18 m
-5,00 m
100,00 m
Income tax expense
21,20 m
38,97 m
-16,00 m
-5,00 m
Effective tax rate
12,46%
14,75%
18,18%
3,55%
Other operating expenses
-
-
-
-
Net income
148,92 m
225,21 m
-72,00 m
-136,00 m
Net profit margin
18,62%
24,16%
-5,68%
-8,27%
Earnings per share
3,40
4,53
2,70
3,05
Interest and investment income
4,71 m
5,67 m
6,00 m
5,00 m
Interest expense
-26,64 m
-14,29 m
-48,00 m
-60,00 m
Net interest expenses
-21,92 m
-8,62 m
-42,00 m
-55,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
271,79 m
367,28 m
243,00 m
456,00 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme